Welcome to the site of
Professor Rabbi Martin
Specialist in Neurology
Professor Jose Martin Rabey
Prof. Rabey was born in Argentina and received his degree in medicine (MD) in 1967 from the University of Buenos Aires. He moved to Israel in 1971. He obtained board certification in neurology in 1973. He worked at the Tel Aviv Medical Center (Ichilov Hospital) till 1995 when he was elected to chair the Department of Neurology at Assaf Harofe Medical Center, a University Hospital annexed to Tel Aviv University. He was the Chairman of the Cathedra of Neurology at Tel Aviv University since 2000 till 2003. He is a full Professor in Neurology at Tel Aviv University since 1996. He has published more than 200 original articles in the field of his specialization: Neurochemistry and Neuropharmacology. He authored chapters in several books in the field of his specialization. He is an international expert in Parkinson’s and Alzheimer Disease. During his career he worked several years in research in the USA – working with the late Menek Goldstein in the University Medical Center of New York; Franz Hefti in the Parkinson National Foundation in Miami, and with R. Burns at the Nerve Disorder Research Laboratory in Nashville, among others. He is considered one of the leading neurologists in the field of Movement Disorders. He was the active Chairman of the Scientific Advisory board for the Israeli Parkinson Association from 2000 till 2007. In 2003 he developed with some colleagues from Europe the SPES, (Short Parkinson Evaluation Scale) which is considered a very practical scoring scale for the evaluation of Parkinson patients that is frequently used in Europe.
Recently with the help of several scientists Prof. Rabey successfully characterized a panel of 5 genes in blood samples of patients with Parkinson's and differentiate them from healthy controls.Those findings can help in the early diagnosis of Parkinson’s disease. This Parkinson’s disease diagnostic blood test is an important breakthrough allowing for early diagnosis that can improve the follow-up and treatment of this disabling disorder. Findings were reported in Molecular Neurodegeneration – a prestigious scientific journal on October 2012.
Concerning Alzheimer disease Prof. Rabey was the first in the world to apply a new technique for the treatment of Alzheimer disease utilizing repetitive Transcranial Magnetic Stimulation (rTMS) combined with Cognitive training.. The new technique has been published in 2 pivotal articles in JNT in 2012 and 2013. Presently there are 5 centers in USA and 3 in Europe applying the technique which we think will be approved by the FDA in the following 1 to 2 years to be used as a new non-invasive technique to control the symptoms of Alzheimer.